Advertisement
For more than a decade, MEDai's Risk Navigator Clinical(R) has accuratelyidentified prospective high- risk patients to help its clients improve memberhealth and quality of care while controlling cost. Risk Navigator Clinicalalso predicts inpatient stays, ER visits and pharmacy costs, and provideschronic and acute cost avoidance scores. These predictions allow clients tofocus time and efforts on areas of high impact. "MEDai's solutions help caremanagers better administer the health of their population by identifyingindividuals that could provide significant savings by managing futureutilization or by adhering to evidenced-based care guidelines," said SwatiAbbott, president of MEDai.
Advertisement
Specifically, Risk Navigator Clinical's Chronic Impact model focuses onthe evaluation of patterns in an organization's data around evidence-basedmedicine (EBM) guidelines. Each condition is supported by a series of clinicalguidelines conforming to the clinical measures defined by nationally-recognized organizations such as HEDIS, AQA, and CMS. The model identifiesspecific diseases and guidelines that if not managed can result in high futurecosts.
About MEDai
MEDai, Inc. is a leading health information company offering award-winningsolutions for the improvement of healthcare delivery. Utilizing cutting-edgetechnology, payors and care management organizations are able to forecastpatients at risk, identify cost drivers for their high-risk population,forecast future health plan costs, evaluate patient patterns over time andimprove outcomes. For more information on MEDai, visit www.medai.com.For More Information Contact: Lizzy Feliciano, MBA Manager Marketing & Communications MEDai, Inc. (800) 446-3324
SOURCE MEDai, Inc.
